Search research articles
Contact Us
Filters
Showing results (11-20 of 45) with videos related to
Page
of 5
Sort By:
European Journal of Clinical Pharmacology
|
September 20, 2012
ACE inhibitors and ribavirin-associated cough: a common undefined predisposing factor?
Laura Milazzo, Dario Cattaneo, Stefania Cheli, et al.
Pharmaceutics
|
July 29, 2023
Therapeutic Drug Monitoring of Anti-TNFα Inhibitors: A Matter of Cut-Off Ranges
Stefania Cheli, Diego Savino, Francesca Penagini, et al.
European Journal of Clinical Pharmacology
|
February 19, 2022
Fast clearance of anti-TNFα agents unrelated to antidrug antibodies: a case report
Stefania Cheli, Valeria Cozzi, Dario Cattaneo, et al.
Cureus
|
November 18, 2024
High Symptom Burden in Patients With Advanced Chronic or Prolonged Infectious Diseases: Not Only Pain
Elena Angeli, Agostino Zambelli, Oscar Corli, et al.
Bipolar Disorders
|
February 28, 2019
Pharmacogenetic variants in bipolar disorder with elevated treatment resistance and intolerance: Towards a personalized pattern of care
Cecilia Casetta, Cristina Montrasio, Stefania Cheli, et al.
Expert Review of Neurotherapeutics
|
March 6, 2024
Evaluating the 6-month formulation of paliperidone palmitate: a twice-yearly injectable treatment for schizophrenia in adults
Giovanna Cirnigliaro, Vera Battini, Michele Castiglioni, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
May 3, 2021
In linezolid underexposure, pharmacogenetics matters: The role of CYP3A5
Stefania Cheli, Marta Fusi, Annalisa De Silvestri, et al.
European Journal of Clinical Pharmacology
|
April 26, 2013
Levofloxacin-induced seizures in a patient without predisposing risk factors: the impact of pharmacogenetics
Cristina Gervasoni, Dario Cattaneo, Felicia Stefania Falvella, et al.
Plos One
|
June 23, 2011
Expression profiling of FSHD-1 and FSHD-2 cells during myogenic differentiation evidences common and distinctive gene dysregulation patterns
Stefania Cheli, Stephanie François, Beatrice Bodega, et al.
Pharmaceuticals (Basel, Switzerland)
|
January 28, 2026
Off-Label Ustekinumab and Vedolizumab in Pediatric Anti-TNFα Refractory IBD: Therapeutic Drug Monitoring Insights from a Case Series
Stefania Cheli, Giulia Mosini, Vera Battini, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 45) with videos related to
Sort By:
Page
of 5
European Journal of Clinical Pharmacology
|
September 20, 2012
ACE inhibitors and ribavirin-associated cough: a common undefined predisposing factor?
Laura Milazzo, Dario Cattaneo, Stefania Cheli, et al.
Pharmaceutics
|
July 29, 2023
Therapeutic Drug Monitoring of Anti-TNFα Inhibitors: A Matter of Cut-Off Ranges
Stefania Cheli, Diego Savino, Francesca Penagini, et al.
European Journal of Clinical Pharmacology
|
February 19, 2022
Fast clearance of anti-TNFα agents unrelated to antidrug antibodies: a case report
Stefania Cheli, Valeria Cozzi, Dario Cattaneo, et al.
Cureus
|
November 18, 2024
High Symptom Burden in Patients With Advanced Chronic or Prolonged Infectious Diseases: Not Only Pain
Elena Angeli, Agostino Zambelli, Oscar Corli, et al.
Bipolar Disorders
|
February 28, 2019
Pharmacogenetic variants in bipolar disorder with elevated treatment resistance and intolerance: Towards a personalized pattern of care
Cecilia Casetta, Cristina Montrasio, Stefania Cheli, et al.
Expert Review of Neurotherapeutics
|
March 6, 2024
Evaluating the 6-month formulation of paliperidone palmitate: a twice-yearly injectable treatment for schizophrenia in adults
Giovanna Cirnigliaro, Vera Battini, Michele Castiglioni, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
May 3, 2021
In linezolid underexposure, pharmacogenetics matters: The role of CYP3A5
Stefania Cheli, Marta Fusi, Annalisa De Silvestri, et al.
European Journal of Clinical Pharmacology
|
April 26, 2013
Levofloxacin-induced seizures in a patient without predisposing risk factors: the impact of pharmacogenetics
Cristina Gervasoni, Dario Cattaneo, Felicia Stefania Falvella, et al.
Plos One
|
June 23, 2011
Expression profiling of FSHD-1 and FSHD-2 cells during myogenic differentiation evidences common and distinctive gene dysregulation patterns
Stefania Cheli, Stephanie François, Beatrice Bodega, et al.
Pharmaceuticals (Basel, Switzerland)
|
January 28, 2026
Off-Label Ustekinumab and Vedolizumab in Pediatric Anti-TNFα Refractory IBD: Therapeutic Drug Monitoring Insights from a Case Series
Stefania Cheli, Giulia Mosini, Vera Battini, et al.
Page
of 5